Literature DB >> 15494446

Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels.

Jason L Scragg1, Ian M Fearon, John P Boyle, Stephen G Ball, Gyula Varadi, Chris Peers.   

Abstract

We examined the effects of chronic hypoxia on recombinant human L-type Ca2+ channel alpha1C subunits stably expressed in HEK 293 cells, using whole-cell patch-clamp recordings. Current density was dramatically increased following 24 h exposure to chronic hypoxia (CH), and membrane channel protein levels were enhanced. CH also increased the levels of Alzheimer's amyloid beta peptides (AbetaPs), determined immunocytochemically. Pharmacological prevention of AbetaP production (via exposure to inhibitors of secretase enzymes that are required to cleave AbetaP from its precursor protein) prevented hypoxic augmentation of currents, as did inhibition of vesicular trafficking with bafilomycin A1. The enhancing effect of AbetaPs or CH were abolished following incubation with the monoclonal 3D6 antibody, raised against the extracellular N' terminus of AbetaP. Immunolocalization and immunoprecipitation studies provided compelling evidence that AbetaPs physically associated with the alpha1C subunit, and this association was promoted by hypoxia. These data suggest an important role for AbetaPs in mediating the increase in Ca2+ channel activity following CH and show that AbetaPs act post-transcriptionally to promote alpha1C subunit insertion into (and/or retention within) the plasma membrane. Such an action will likely contribute to the Ca2+ dyshomeostasis of Alzheimer's disease and may contribute to the mechanisms underlying the known increased incidence of this neurodegenerative disease following hypoxic episodes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494446     DOI: 10.1096/fj.04-2659fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  20 in total

1.  Reduction in neuronal L-type calcium channel activity in a double knock-in mouse model of Alzheimer's disease.

Authors:  Olivier Thibault; Tristano Pancani; Philip W Landfield; Christopher M Norris
Journal:  Biochim Biophys Acta       Date:  2012-01-10

2.  Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography.

Authors:  Mary Ellen I Koran; Timothy J Hohman; Tricia A Thornton-Wells
Journal:  Hum Genet       Date:  2013-09-12       Impact factor: 4.132

Review 3.  A central role for ROS in the functional remodelling of L-type Ca2+ channels by hypoxia.

Authors:  Chris Peers; Jason L Scragg; John P Boyle; Ian M Fearon; Shafeena C Taylor; Kim N Green; Nicola J Webster; Martin Ramsden; Hugh A Pearson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

4.  Effects of amyloid-β peptides on voltage-gated L-type Ca(V)1.2 and Ca(V)1.3 Ca(2+) channels.

Authors:  Sunoh Kim; Hyewhon Rhim
Journal:  Mol Cells       Date:  2011-08-04       Impact factor: 5.034

5.  Amyloid-Beta Modulates Low-Threshold Activated Voltage-Gated L-Type Calcium Channels of Arcuate Neuropeptide Y Neurons Leading to Calcium Dysregulation and Hypothalamic Dysfunction.

Authors:  Makoto Ishii; Abigail J Hiller; Laurie Pham; Matthew J McGuire; Costantino Iadecola; Gang Wang
Journal:  J Neurosci       Date:  2019-09-19       Impact factor: 6.167

6.  L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease.

Authors:  Thimmappa S Anekonda; Joseph F Quinn; Christopher Harris; Kate Frahler; Teri L Wadsworth; Randall L Woltjer
Journal:  Neurobiol Dis       Date:  2010-09-09       Impact factor: 5.996

7.  Role of KATP and L-type Ca2+ channel activities in regulation of ovine uterine vascular contractility: effect of pregnancy and chronic hypoxia.

Authors:  Daliao Xiao; Lawrence D Longo; Lubo Zhang
Journal:  Am J Obstet Gynecol       Date:  2010-12       Impact factor: 8.661

Review 8.  α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum.

Authors:  Victor V Uteshev
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 9.  Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration?

Authors:  O O Ogunshola; X Antoniou
Journal:  Cell Mol Life Sci       Date:  2009-09-11       Impact factor: 9.261

10.  The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.

Authors:  F Peña; Ai Gutiérrez-Lerma; R Quiroz-Baez; C Arias
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.